MNKD

#2582
Mannkind Corporation
2.6950 USD
+2.08%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
2.6800
2.7000
Rango anual
2.2300
6.5100
Cambio diario
+2.08%
Variación mensual
-2.71%
Variación en los últimos 6 meses
-49.15%
Cambio anual
-49.15%
Cierres anteriores
2.6400
Abrir
2.6800
Bid
Ask
Mínimo
2.6800
High
2.7000
Volumen
117
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 830.3307 M
  • Employee 592
  • Founded N/A
  • CEO Michael Castagna
  • Website www.mannkindcorp.com
  • Headquarter Delaware, United States
  • FIGI BBG000PPL3G9
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
283.5
Relación precio/flujo de caja
5.25

MannKind Corporation

MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991. MannKind Corporation was named after its founder, Alfred E. Mann.

Noticias